Literature DB >> 20065376

Terrible triad of the elbow.

Roberto Seijas1, Oscar Ares-Rodriguez, Adolfo Orellana, Daniel Albareda, Diego Collado, Manel Llusa.   

Abstract

PURPOSE: To review epidemiological characteristics and treatment outcomes of the terrible triad of the elbow.
METHODS: Records of 18 cases of the terrible triad of the elbow occurring in 8 women and 8 men aged 17 to 77 (mean, 45) years were reviewed. The epidemiology and various treatment approaches and functional outcomes were recorded. The mean follow-up period was 13.6 (range, 4-38) months. The injury mechanisms included simple falls (n=12), falls from a low height (n=2), traffic accidents (n=2), and sports accidents (n=2). Radial head fractures and the coronoid apophysis fractures were classified.
RESULTS: There were 10 type-III and 8 type-II radial head fractures, 9 type-I and 9 type-II coronoid apophysis fractures, and all humeroulnar dislocations were posterior. The mean duration of immobilisation was 25.5 (range, 17-38) days. After rehabilitation, the mean range of motion of the elbow improved to 130 degrees flexion (24% recovery), 18 degrees extension (35% recovery), 73 degrees supination (142% recovery), and 85 degrees pronation (25% recovery). The greatest gain in range of motion occurred within 3 to 4 months. Complications included heterotopic ossification (n=4), blocked pronation and supination (n=4), transient ulnar nerve injury (n=2), Essex-Lopresti lesion (n=2), unnoticed dislocation (n=3), and rapidly progressive arthrosis (n=1).
CONCLUSION: Although our patients had better recovery of range of motion than those reported in other studies, the terrible triad of the elbow can lead to joint instability, osteoarthritis, arthrosis, and joint stiffness, and may resort to total elbow arthroplasty in some cases.

Entities:  

Mesh:

Year:  2009        PMID: 20065376     DOI: 10.1177/230949900901700319

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

1.  What Factors Are Associated with Reoperation After Operative Treatment of Terrible Triad Injuries?

Authors:  Peter J Ostergaard; Matthew A Tarabochia; Matthew J Hall; George Dyer; Brandon E Earp; Philip Blazar; Dafang Zhang
Journal:  Clin Orthop Relat Res       Date:  2021-01-01       Impact factor: 4.755

Review 2.  Complex Elbow Dislocations and the "Terrible Triad" Injury.

Authors:  Alistair D R Jones; Robert W Jordan
Journal:  Open Orthop J       Date:  2017-11-30

3.  Surgical treatment for terrible triad injury of the elbow with anteromedial coronoid fracture through a combined surgical approach.

Authors:  Guanyi Liu; Jingen Hu; Weihu Ma; Ming Li; Rongming Xu; Zhijun Pan
Journal:  J Int Med Res       Date:  2018-07-20       Impact factor: 1.671

4.  Replacement or repair of terrible triad of the elbow: A systematic review and meta-analysis.

Authors:  Hongwei Chen; Yinchu Shao; Shaobo Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Result from surgical treatment on the terrible triad of the elbow.

Authors:  Anderson de Aquino Santos; Thomaz Antônio Tonelli; Fabio Teruo Matsunaga; Marcelo Hide Matsumoto; Nicola Archetti Netto; Marcel Jun Sugawara Tamaoki
Journal:  Rev Bras Ortop       Date:  2015-07-03

6.  Terrible triad of the elbow: influence of radial head treatment.

Authors:  Lucas Braga Jaques Gonçalves; Jorge de Almeida E Silva Neto; Mario Roberto Chaves Correa Filho; Ronaldo Percope de Andrade; Marco Antônio Percope de Andrade; Anderson Humberto Gomes; José Carlos Souza Vilela
Journal:  Rev Bras Ortop       Date:  2014-07-11

Review 7.  Complications of treating terrible triad injury of the elbow: a systematic review.

Authors:  Hong-wei Chen; Guo-dong Liu; Li-jun Wu
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

8.  Risk factors of efficacy for patients receiving surgical treatment following terrible triad of the elbow joint: A comparative study.

Authors:  Hong-Wei Chen; Shu-Ming Huang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.